Buy Xovoltib : Afatinib 40 Mg Tablets 28’S Online

Description

Xovoltib is a pharmaceutical formulation manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., designed to provide therapeutic benefits in the treatment of certain types of cancer. Each pack contains 28 tablets, with each tablet containing 40 mg of Afatinib, the active ingredient.

Key Features:

1. Active Ingredient: Xovoltib contains Afatinib, a potent inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2). This mechanism of action makes it effective in treating specific types of cancer, notably non-small cell lung cancer (NSCLC) and certain types of metastatic breast cancer.
2. Precision Dosing: Each tablet is precisely dosed with 40 mg of Afatinib, ensuring consistency and accuracy in treatment.
3. Convenient Packaging: Xovoltib comes in a pack of 28 tablets, providing a convenient supply for a treatment cycle.
4. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.: Boehringer Ingelheim Pharmaceuticals, Inc., a renowned pharmaceutical company with a global presence, manufactures Xovoltib. The company is committed to innovation and excellence in the development of oncology therapies.

Indications:

• Xovoltib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations, including exon 19 deletions or exon 21 (L858R) substitutions.
• It is also indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and have received prior treatment with trastuzumab.

Dosage and Administration:

• The dosage of Xovoltib should be individualized based on patient factors, including overall health status, tolerability, and concomitant medications.
• Patients should follow the dosage regimen prescribed by their healthcare provider.
• Xovoltib tablets are typically taken orally, with or without food, as directed by a healthcare professional.

Storage Information:

• Store Xovoltib tablets at room temperature (15-30°C).
• Keep the tablets in their original packaging to protect them from light and moisture.
• Keep Xovoltib out of reach of children.

Precautions and Warnings:

• Xovoltib should only be used under the supervision of a qualified healthcare professional experienced in the use of anticancer agents.
• Patients should be monitored regularly for adverse reactions and treatment efficacy.
• Use caution in patients with pre-existing liver or kidney dysfunction.
• Avoid concomitant use of Xovoltib with strong CYP3A4 inducers or inhibitors.

Disclaimer:

• Xovoltib Afatinib 40 mg Tablets 28’s is a prescription medication. Patients should consult their healthcare provider before starting treatment with Xovoltib.
• This product description provides general information about Xovoltib and is not intended to replace medical advice. Patients should seek advice from their healthcare provider regarding their specific medical condition and treatment options.